Economics ❯ Market Trends ❯ Stock Performance ❯ Analyst Ratings

Pfizer Stock

Pfizer–Trump Drug-Pricing Deal and ‘TrumpRx’ Plan Jolt Health-Care Stocks Higher

The agreement links Medicaid price cuts to a three-year tariff reprieve for Pfizer, signaling clearer policy direction.